Post Marketing Surveillance: What Is the Potential for Harm When Use Is Not Consistent with the Trial Population in People Receiving Cholinesterase Inhibitors for Treatment of Alzheimer's Dementia?
- Resource Type
- Journal
- Source
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY ; AUG 2009, 18 pS174-pS174, 1p.- Subject
- Language
- English
- ISSN
- 10538569